NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

India's Small- and Mid-Cap Stocks Attract Investors Amid Strong Earnings and Valuation Corrections

India's small- and mid-cap stocks are poised to benefit from a combination of stronger earnings, price corrections, and improving valuations, making them more attractive than large-cap stocks. This sentiment is shared by Hiren Dasani, chief investment officer for emerging markets at Singapore-based WhiteOak Capital, which has a global asset under management (AUM) of $11.23 billion, with 40% of its assets allocated to India.

According to Dasani, the real opportunity lies in companies tied to powerful structural themes such as manufacturing, supply-chain diversification, defense, energy infrastructure, and AI-linked global capital expenditure. These themes are better represented in the broader market than in the large-cap universe. Despite elevated crude prices and foreign outflows, the long-term growth story of domestic markets remains intact, according to WhiteOak.

Market performance shows a divergence. India's Nifty 50 and Sensex have declined 8.3% and 10.5% respectively in 2026, while small-caps and mid-caps have gained 2.6% and 2.2% respectively.

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Market Index2026 Performance
Nifty 50-8.3%
Sensex-10.5%
Small-caps2.6%
Mid-caps2.2%

Foreign portfolio investors have offloaded domestic stocks worth $23.86 billion in 2026 so far, surpassing last year's record annual outflows. However, Dasani views the selling as a valuation reset rather than a rejection of India's fundamentals. He believes that India's 10%–12% earnings growth outlook remains intact, but investors are reassessing it against improving earnings visibility in other emerging markets such as Korea and Taiwan, driven by AI-led capital expenditure.

Record buying by domestic mutual funds in small- and mid-caps in April remains a key supportive factor for these segments, according to WhiteOak Capital. The fund house favors industrials, manufacturing, and select financials, citing strong momentum in engineering firms, auto ancillaries, and capital-goods companies, with multi-year growth visibility.

WhiteOak also sees opportunities in non-banking financial companies, MSME lenders, and microfinance firms, where credit costs appear to have peaked. However, it is cautious on IT services as AI-driven productivity gains intensify pricing pressure.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

WhiteOak has significant exposure to Indian small- and mid-cap stocks, with its flexi-cap, multi-cap, and special opportunities funds managing 79.07 billion rupees ($829.09 million), 34.21 billion rupees, and 15.39 billion rupees respectively.

Investor Takeaway

Investors should consider small- and mid-cap stocks due to their attractive valuations and earnings growth.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.